{"document_type": "article", "byline": [], "news_desk": "Letters", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"kicker": "Letter", "content_kicker": "Letter", "print_headline": "F.D.A.\u2019s Wise Decision", "main": "F.D.A.\u2019s Wise Decision"}, "print_page": "24", "keywords": [{"value": "Abortion Drugs", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "2", "name": "organizations"}], "snippet": "A reader praises the F.D.A.\u2019s decision to ease access to the pill as based on science, not politics.", "source": "The New York Times", "lead_paragraph": "A reader praises the F.D.A.\u2019s decision to ease access to the pill as based on science, not politics.", "word_count": "182", "pub_date": "2016-04-01T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "Letter", "section_name": "Opinion", "web_url": "http://www.nytimes.com/2016/04/01/opinion/fdas-new-rules-on-abortion-pill.html", "_id": "56fd6c0338f0d85faa67c40e"}